← 產業報告目錄

Global Microsurgery & Super-Microsurgery Market by Equipment (Operating Microscopes, Super Micro Sutures, Micro Forceps, Microsurgery Needle Holder, Surgical Scalpel/ Ophthalmic Knives, Others), by Procedure (Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery, Others), by End User (Hospitals, Ambulatory Surgical Centers, Others), by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2025-07-07頁數 148報告編號 MRFRHC19909CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Global Microsurgery & Super-Microsurgery Market by Equipment (Operating Microscopes, Super Micro Sutures, Micro Forceps, Microsurgery Needle Holder, Surgical Scalpel/ Ophthalmic Knives, Others), by Procedure (Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery, Others), by End User (Hospitals, Ambulatory Surgical Centers, Others), by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2032 Market Overview Global microsurgery and super-microsurgery market was estimated to be worth USD 1,961.54 million in 2022 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.07% from 2023 to 2032, reaching USD 3,783.66 million in 2032. Global microsurgery and super-microsurgery market is driven by the increasing volume of surgical procedures and the rising geriatric population. Advancements in R&D, growing transplant surgeries, and the need for precision in orthopedic and reconstructive procedures contribute significantly. Aging-related conditions and chronic diseases further boost demand for microsurgical interventions with high success rates across medical disciplines. Global microsurgery and super-microsurgery market faces restraints due to risks like infection, poor healing, nerve damage, scarring, anesthesia complications, and potential need for revision surgeries. Global microsurgery and super-microsurgery market is poised for growth due to the rising prevalence of lifestyle disorders and ongoing technological advancements. Increasing product approvals, government support, and innovation, such as developments in ophthalmic surgical microscopes, are enhancing procedural precision. As chronic diseases rise among both aging and younger populations, the demand for advanced microsurgical solutions is expected to surge. Market Segmentations Global microsurgery and super-microsurgery market is categorized based on equipment type and surgical procedures. The equipment segment comprises operating microscopes, super micro sutures, micro forceps, microsurgery needle holders, surgical scalpels or ophthalmic knives, and other related tools. Orthopedic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Ophthalmic Microsurgery, Gynecological & Urological Microsurgery are the part of procedure types of global market. In terms of end user, global microsurgery and super microsurgery market is categorized into hospitals and ambulatory surgical centers and others. Based on the regional category, global microsurgery and super microsurgery market has been segmented into North America, Europe, Asia Pacific, and rest of the world. Regional Insights Global microsurgery and super-microsurgery market has seen notable regional developments, each shaped by unique drivers and challenges. In North America, market growth has been robust, driven by continuous technological advancements and an increasing preference for minimally invasive procedures across several specialties. In Europe, the market has evolved significantly, fueled by innovations in medical technology, a growing elderly population, and the rising prevalence of chronic conditions. Both microsurgeries, using fine instruments and microscopes, and the more advanced super-microsurgery have become integral in fields such as plastic surgery, ophthalmology, orthopedics, and reconstructive surgery. The Asia Pacific region is witnessing rapid progress due to its strong focus on research and development. Leading academic and medical institutions are pioneering new techniques, enhancing the precision and scope of these delicate surgical procedures. Meanwhile, in the Middle East, Africa, and Latin America, the market is expanding but faces notable challenges. Although there is growing interest, limited access to specialized training, high equipment costs, and uneven healthcare infrastructure restrict the broader adoption of microsurgery and super-microsurgery across these regions. Major Players Johnson & Johnson Services Inc, Carl Zeiss Meditec, KLS Martin Group, Topcon Corporation, Olympus Corporation, Kontron AG, B. Braun SE, Zimmer Biomet, Global Surgical Corporation, Karl Kaps GmbH & Co. KG, Smith+Nephew, Stille AB, Medtronic, Stryker, BVI, Microsurgery Instruments Inc, Haag-Streit Group, Peter Lazic GmbH, Alco Inc, Synovis Micro Companies Alliance Inc. are the key companies of global microsurgery and super microsurgery market.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ................. 22 2 MARKET INTRODUCTION .............. 24 2.1 DEFINITION .................................................................... 24 2.2 SCOPE OF THE STUDY ................................................ 24 2.3 RESEARCH OBJECTIVE .............................................. 24 2.4 MARKET STRUCTURE ................................................ 24 3 RESEARCH METHODOLOGY ........ 25 3.1 OVERVIEW ...................................................................... 25 3.2 DATA FLOW .................................................................... 27 3.2.1 DATA MINING PROCESS ......................................... 27 3.3 PURCHASED DATABASE: ........................................... 28 3.4 SECONDARY SOURCES: .............................................. 29 3.4.1 SECONDARY RESEARCH DATA FLOW: .......................... 30 3.5 PRIMARY RESEARCH: ................................................. 31 3.5.1 PRIMARY RESEARCH DATA FLOW: ......................... 32 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ........................................................................................ 33 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ............... 33 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 34 3.6.1 REVENUE ANALYSIS APPROACH .............................. 34 3.7 DATA FORECASTING................................................... 34 3.7.1 DATA FORECASTING TECHNIQUE .............................. 35 3.8 DATA END USERLING ................................................. 36 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ......................... 36 3.8.2 DATA END USERLING: ............................................ 37 3.9 TEAMS AND ANALYST CONTRIBUTION ............. 38 4 MARKET DYNAMICS ...................... 40 4.1 INTRODUCTION ............................................................. 40 4.2 DRIVERS ........................................................................... 41 4.2.1 GROWING NUMBER OF SURGICAL PROCEDURES ............. 41 4.2.2 INCREASING NUMBER OF GERIATRIC POPULATION .......... 41 4.3 RESTRAINTS .................................................................. 42 4.3.1 COMPLICATIONS AND RISKS DUE TO THE PROCEDURE .... 42 4.4 OPPORTUNITY ............................................................... 43 4.4.1 INCREASING INCIDENCE OF LIFESTYLE DISORDERS AND GROWING TECHNOLOGICAL ADVANCEMENTS ........................................ 43 5 MARKET FACTOR ANALYSIS ........ 45 5.1 VALUE CHAIN ANALYSIS ......................................... 45 5.1.1 R&D ................................................................. 46 5.1.2 MANUFACTURING .................................................. 46 5.1.3 DISTRIBUTION AND SALES ...................................... 47 5.1.4 POST-SALES MONITORING ....................................... 47 5.2 PORTER’S FIVE FORCES MODEL ............................. 48 5.2.1 THREAT OF NEW ENTRANTS ..................................... 49 5.2.2 BARGAINING POWER OF SUPPLIERS ........................... 49 5.2.3 THREAT OF SUBSTITUTES ........................................ 49 5.2.4 BARGAINING POWER OF BUYERS .............................. 49 5.2.5 INTENSITY OF RIVALRY ............................................ 49 5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET ... 50 5.3.1 IMPACT ON SUPPLY CHAIN ..................................... 50 5.3.2 IMPACT ON KEY PLAYERS ................................ 50 5.3.3 IMPACT ON DEMAND AND SUPPLY ................... 51 6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT .............. 52 6.1 OVERVIEW ...................................................................... 52 6.2 OPERATING MICROSCOPES ...................................... 55 6.3 SUPER MICRO SUTURES ............................................ 55 6.4 MICRO FORCEPS ........................................................... 56 6.5 MICROSURGERY NEEDLE HOLDER ........................ 56 6.6 SURGICAL SCALPEL/ OPHTHALMIC KNIVES ..... 57 6.7 OTHERS ............................................................................ 57 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE ............ 58 7.1 OVERVIEW ...................................................................... 58 7.2 ORTHOPEDIC MICROSURGERY ................................ 61 7.3 OPHTHALMIC MICROSURGERY .............................. 62 7.4 PLASTIC & RECONSTRUCTIVE MICROSURGERY ............................................................................................ 62 7.5 ENT MICROSURGERY .................................................. 63 7.6 NEUROLOGICAL MICROSURGERY .......................... 63 7.7 GYNECOLOGICAL & UROLOGICAL MICROSURGERY ....................................................................................... 64 7.8 OTHERS ............................................................................ 64 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER ................. 65 8.1 OVERVIEW ...................................................................... 65 8.2 HOSPITALS ..................................................................... 67 8.3 AMBULATORY SURGICAL CENTERS ..................... 68 8.4 OTHERS ............................................................................ 68 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION ...................... 69 9.1 OVERVIEW ...................................................................... 69 9.2 NORTH AMERICA ......................................................... 71 9.2.1 US.................................................................... 75 9.2.2 CANADA .......................................................... 76 9.3 EUROPE ............................................................................ 78 9.3.1 GERMANY .......................................................... 82 9.3.2 FRANCE ............................................................. 83 9.3.3 UK ................................................................... 85 9.3.4 ITALY ................................................................. 86 9.3.5 SPAIN ............................................................... 88 9.3.6 REST OF EUROPE .................................................. 89 9.4 ASIA-PACIFIC ................................................................. 91 9.4.1 CHINA .............................................................. 95 9.4.2 JAPAN ............................................................. 96 9.4.3 INDIA ............................................................... 98 9.4.4 AUSTRALIA ...................................................... 99 9.4.5 SOUTH KOREA .................................................. 101 9.4.6 REST OF ASIA-PACIFIC ..................................... 102 9.5 REST OF WORLD ........................................................... 104 9.5.1 MIDDLE EAST ................................................... 108 9.5.2 SOUTH AMERICA .............................................. 109 10 COMPETITIVE LANDSCAPE .......... 111 10.1 INTRODUCTION ............................................................. 111 10.2 MARKET SHARE ANALYSIS, 2022 ......................... 111 10.3 COMPETITOR DASHBOARD....................................... 112 10.4 PUBLIC PLAYERS STOCK SUMMARY ................... 114 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL .............................................................................. 114 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................... 115 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL ......... 115 1 0.6.2 ACQUISITION/INVESTMENT/EXPANSION .......... 115 10.7 COMPETITOR PRODUCT ANALYSIS ...................... 116 10.7.1 OPERATING MICROSCOPES .............................. 116 10.7.2 MICRO FORCEPS .............................................. 117 10.7.3 SUPER MICRO SUTURES ................................... 118 10.7.4 MICROSURGERY NEEDLE HOLDER ..................... 119 10.7.5 SURGICAL SCALPEL/ OPHTHALMIC KNIVES ...... 120 11 COMPANY PROFILES .................... 121 11.1 KONTRON AG ................................................................. 121 11.1.1 COMPANY OVERVIEW ....................................... 121 11.1.2 FINANCIAL OVERVIEW ...................................... 122 11.1.3 PRODUCTS OFFERED ........................................ 123 11.1.4 KEY DEVELOPMENTS ........................................ 124 11.1.5 KEY STRATEGIES .............................................. 124 11.2 CARL ZEISS MEDITEC AG .......................................... 125 11.2.1 COMPANY OVERVIEW ....................................... 125 11.2.2 FINANCIAL OVERVIEW ...................................... 126 11.2.3 PRODUCTS OFFERED ........................................ 126 11.2.4 KEY DEVELOPMENTS ........................................ 129 11.2.5 SWOT ANALYSIS .............................................. 130 11.2.6 KEY STRATEGIES .............................................. 130 11.3 GLOBAL SURGICAL CORPORATION ........................ 131 11.3.1 COMPANY OVERVIEW ....................................... 131 11.3.2 FINANCIAL OVERVIEW ...................................... 131 11.3.3 PRODUCTS OFFERED ........................................ 132 11.3.4 KEY DEVELOPMENTS ........................................ 132 11.3.5 KEY STRATEGIES .............................................. 132 11.4 KARL KAPS GMBH & CO. KG ..................................... 133 11.4.1 COMPANY OVERVIEW ....................................... 133 11.4.2 FINANCIAL OVERVIEW ...................................... 133 11.4.3 PRODUCTS OFFERED ........................................ 134 11.4.4 KEY DEVELOPMENTS ........................................ 134 11.4.5 KEY STRATEGIES .............................................. 134 11.5 MEDTRONIC ................................................................... 135 11.5.1 COMPANY OVERVIEW ....................................... 135 11.5.2 FINANCIAL OVERVIEW ...................................... 136 11.5.3 PRODUCTS OFFERED ........................................ 137 11.5.4 KEY DEVELOPMENTS ........................................ 137 11.5.5 SWOT ANALYSIS .............................................. 138 11.5.6 KEY STRATEGIES .............................................. 138 11.6 OLYMPUS CORPORATION ......................................... 139 11.6.1 COMPANY OVERVIEW ....................................... 139 11.6.2 FINANCIAL OVERVIEW ...................................... 140 11.6.3 PRODUCTS OFFERED ........................................ 140 11.6.4 KEY DEVELOPMENTS ........................................ 141 11.6.5 KEY STRATEGIES .............................................. 141 11.7 SMITH+NEPHEW .......................................................... 142 11.7.1 COMPANY OVERVIEW ....................................... 142 11.7.2 FINANCIAL OVERVIEW ...................................... 143 11.7.3 PRODUCTS OFFERED ........................................ 144 11.7.4 KEY DEVELOPMENTS ........................................ 144 11.7.5 KEY STRATEGIES .............................................. 144 11.8 ZIMMER BIOMET .......................................................... 145 11.8.1 COMPANY OVERVIEW ....................................... 145 11.8.2 FINANCIAL OVERVIEW ...................................... 146 11.8.3 PRODUCTS OFFERED ........................................ 146 11.8.4 KEY DEVELOPMENTS ........................................ 149 11.8.5 SWOT ANALYSIS .............................................. 149 11.8.6 KEY STRATEGIES .............................................. 149 11.9 TOPCON CORPORATION ............................................. 150 11.9.1 COMPANY OVERVIEW ....................................... 150 11.9.2 FINANCIAL OVERVIEW ...................................... 151 11.9.3 PRODUCTS OFFERED ........................................ 152 11.9.4 KEY DEVELOPMENTS ........................................ 152 11.9.5 KEY STRATEGIES .............................................. 153 11.10 STILLE AB ....................................................................... 154 11.10.1 COMPANY OVERVIEW ....................................... 154 11.10.2 FINANCIAL OVERVIEW ...................................... 155 11.10.3 PRODUCTS OFFERED ........................................ 155 11.10.4 KEY DEVELOPMENTS ........................................ 156 1 1.10.5 KEY STRATEGIES .............................................. 156 11.11 B. BRAUN SE ................................................................... 157 11.11.1 COMPANY OVERVIEW ....................................... 157 11.11.2 FINANCIAL OVERVIEW ...................................... 158 11.11.3 PRODUCT OFFERED .......................................... 159 11.11.4 KEY DEVELOPMENTS ........................................ 159 11.11.5 SWOT ANALYSIS .............................................. 160 11.11.6 KEY STRATEGY ..................................................... 160 11.12 STRYKER ......................................................................... 161 11.12.1 COMPANY OVERVIEW ....................................... 161 11.12.2 FINANCIAL OVERVIEW ...................................... 162 11.12.3 PRODUCTS OFFERED ............................................ 163 11.12.4 KEY DEVELOPMENTS ........................................ 163 11.12.5 KEY STRATEGIES .............................................. 163 11.13 BVI ..................................................................................... 164 11.13.1 COMPANY OVERVIEW ....................................... 164 11.13.2 FINANCIAL OVERVIEW ...................................... 164 11.13.3 PRODUCTS OFFERED ............................................ 165 11.13.4 KEY DEVELOPMENTS ........................................ 165 11.13.5 KEY STRATEGY ................................................. 165 11.14 JOHNSON & JOHNSON SERVICES INC .................. 166 11.14.1 COMPANY OVERVIEW ....................................... 166 11.14.2 FINANCIAL OVERVIEW ...................................... 167 11.14.3 PRODUCTS OFFERED ........................................ 167 11.14.4 KEY DEVELOPMENTS ........................................ 168 11.14.5 SWOT ANALYSIS .............................................. 168 11.14.6 KEY STRATEGIES .............................................. 168 11.15 HAAG-STREIT GROUP ................................................. 169 11.15.1 COMPANY OVERVIEW ....................................... 169 11.15.2 FINANCIAL OVERVIEW ...................................... 170 11.15.3 PRODUCTSOFFERED ......................................... 170 11.15.4 KEY DEVELOPMENTS ........................................ 170 11.15.5 KEY STRATEGIES .............................................. 170 11.16 KLS MARTIN GROUP ................................................... 171 11.16.1 COMPANY OVERVIEW ....................................... 171 11.16.2 FINANCIAL OVERVIEW ...................................... 172 11.16.3 PRODUCT OFFERED .......................................... 172 11.16.4 KEY DEVELOPMENTS ........................................ 172 11.16.5 KEY STRATEGIES .............................................. 172 11.17 MICROSURGERY INSTRUMENTS, INC .................. 173 11.17.1 COMPANY OVERVIEW ....................................... 173 11.17.2 FINANCIAL OVERVIEW ...................................... 173 11.17.3 PRODUCTS OFFERED......................................... 173 11.17.4 KEY DEVELOPMENTS ........................................ 174 11.17.5 KEY STRATEGIES .............................................. 174 11.18 PETER LAZIC GMBH .................................................... 175 11.18.1 COMPANY OVERVIEW ....................................... 175 11.18.2 FINANCIAL OVERVIEW ...................................... 176 11.18.3 PRODUCT OFFERED .......................................... 176 11.18.4 KEY DEVELOPMENTS ........................................ 176 11.18.5 KEY STRATEGIES .............................................. 176 11.19 ALCON INC ...................................................................... 177 11.19.1 COMPANY OVERVIEW ....................................... 177 11.19.2 FINANCIAL OVERVIEW ...................................... 178 11.19.3 PRODUCT OFFERED .......................................... 178 11.19.4 KEY DEVELOPMENTS ........................................ 179 11.19.5 KEY STRATEGIES .............................................. 179 11.20 SYNOVIS MICRO COMPANIES ALLIANCE, INC .. 180 11.20.1 COMPANY OVERVIEW ....................................... 180 11.20.2 FINANCIAL OVERVIEW ...................................... 181 11.20.3 PRODUCT OFFERED .......................................... 181 11.20.4 KEY DEVELOPMENTS ........................................ 181 11.20.5 KEY STRATEGIES .............................................. 181 12 DATA CITATIONS ........................... 182
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD END USERLING FOR MARKET SHARE ASSESSMENT 37 TABLE 2 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 53 TABLE 3 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR TOPERATING MICROSCOPES, BY REGION, 2019–2032 (USD MILLION) 55 TABLE 4 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SUPER MICRO SUTURES, BY REGION, 2019–2032 (USD MILLION) 55 TABLE 5 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICRO FORCEPS, BY REGION, 2019–2032 (USD MILLION) 56 TABLE 6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICROSURGERY NEEDLE HOLDER, BY REGION, 2019–2032 (USD MILLION) 56 TABLE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SURGICAL SCALPEL/ OPHTHALMIC KNIVES, BY REGION, 2019–2032 (USD MILLION) 57 TABLE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 57 TABLE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 60 TABLE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ORTHOPEDIC MICROSURGERY, BY REGION, 2019–2032 (USD MILLION) 61 TABLE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OPHTHALMIC MICROSURGERY, BY REGION, 2019–2032 (USD MILLION) 62 TABLE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR PLASTIC & RECONSTRUCTIVE MICROSURGERY, BY REGION, 2019–2032 (USD MILLION) 62 TABLE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ENT MICROSURGERY, BY REGION, 2019–2032 (USD MILLION) 63 TABLE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR NEUROLOGICAL MICROSURGERY, BY REGION, 2019–2032 (USD MILLION) 63 TABLE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR GYNECOLOGICAL & UROLOGICAL MICROSURGERY, BY REGION, 2019–2032 (USD MILLION) 64 TABLE 16 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 64 TABLE 17 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2019–2032 (USD MILLION) 66 TABLE 18 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR HOSPITALS, BY REGION, 2019–2032 (USD MILLION) 67 TABLE 19 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION) 68 TABLE 20 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 68 TABLE 21 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2019–2032 (USD MILLION) 70 TABLE 22 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 72 TABLE 23 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 73 TABLE 24 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 74 TABLE 25 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 74 TABLE 26 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 75 TABLE 27 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 75 TABLE 28 US: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 76 TABLE 29 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 76 TABLE 30 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 77 TABLE 31 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 77 TABLE 32 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 79 TABLE 33 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 80 TABLE 34 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 81 TABLE 35 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 81 TABLE 36 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 82 TABLE 37 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 82 TABLE 38 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 83 TABLE 39 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 83 TABLE 40 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 84 TABLE 41 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 84 TABLE 42 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 85 TABLE 43 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 85 TABLE 44 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 86 TABLE 45 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 86 TABLE 46 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 87 TABLE 47 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 87 TABLE 48 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 88 TABLE 49 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 88 TABLE 50 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 89 TABLE 51 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION) 89 TABLE 52 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION) 90 TABLE 53 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION) 90 TABLE 54 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018–2030 (USD MILLION) 93 TABLE 55 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 93 TABLE 56 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 94 TABLE 57 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 94 TABLE 58 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 95 TABLE 59 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 95 TABLE 60 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 96 TABLE 61 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 96 TABLE 62 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 97 TABLE 63 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 97 TABLE 64 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 98 TABLE 65 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 98 TABLE 66 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 99 TABLE 67 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 99 TABLE 68 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 100 TABLE 69 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 100 TABLE 70 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 101 TABLE 71 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 101 TABLE 72 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 102 TABLE 73 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 102 TABLE 74 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 103 TABLE 75 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 103 TABLE 76 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018–2030 (USD MILLION) 106 TABLE 77 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 106 TABLE 78 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 107 TABLE 79 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 107 TABLE 80 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 108 TABLE 81 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 108 TABLE 82 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 109 TABLE 83 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD MILLION) 109 TABLE 84 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION) 110 TABLE 85 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018–2030 (USD MILLION) 110 TABLE 86 PUBLIC PLAYERS STOCK SUMMARY 114 TABLE 87 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 114 TABLE 88 PRODUCT LAUNCH/PRODUCT APPROVAL 115 TABLE 89 ACQUISITION /INVESTMENT/EXPANSION/COLLABORATION 115 TABLE 90 KONTRON AG: PRODUCTS OFFERED 123 TABLE 91 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED 126 TABLE 92 CARL ZEISS MEDITEC AG: KEY DEVELOPMENTS 129 TABLE 93 GLOBAL SURGICAL CORPORATION: PRODCUTS OFFERED 132 TABLE 94 KARL KAPS GMBH & CO. KG: PRODCUTS OFFERED 134 TABLE 95 MEDTRONIC: PRODCUTS OFFERED 137 TABLE 96 OLYMPUS CORPORATION: PRODCUTS OFFERED 140 TABLE 97 SMITH+NEPHEW: PRODCUTS OFFERED 144 TABLE 98 ZIMMER BIOMET: PRODCUTS OFFERED 146 TABLE 99 TOPCON CORPORATION: PRODCUTS OFFERED 152 TABLE 100 STILLE AB: PRODCUTS OFFERED 155 TABLE 101 STILLE AB: KEY DEVELOPMENTS 156 TABLE 102 B. BRAUN SE: PRODUCTS OFFERED 159 TABLE 103 STRYKER: PRODCUTS OFFERED 163 TABLE 104 BVI: PRODCUTS OFFERED 165 TABLE 105 BVI: KEY DEVELOPMENTS 165 TABLE 106 JOHNSON & JOHNSON SERVICES INC: PRODUCTS OFFERED 167 TABLE 107 HAAG-STREIT GROUP: PRODUCTS OFFERED 170 TABLE 108 KLS MARTIN GROUP: PRODUCTSOFFERED 172 TABLE 109 MICROSURGERY INSTRUMENTS, INC: PRODUCTS OFFERED 173 TABLE 110 PETER LAZIC GMBH: PRODUCT OFFERED 176 TABLE 111 ALCON: PRODUCT OFFERED 178 TABLE 112 SYNOVIS MICRO COMPANIES ALLIANCE, INC: PRODUCT OFFERED 181 TABLE 113 SYNOVIS MICRO COMPANIES ALLIANCE, INC: KEY DEVELOPMENTS 181 LIST OF FIGURES FIGURE 1 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET: STRUCTURE 24 FIGURE 2 GLOBAL MICROSURGERY AND SUPER-MICROSURGERY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 40 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 42 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 43 FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET 45 FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET 48 FIGURE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, EQUIPMENT SEGMENT ATTRACTIVENESS, 2019–2032 (USD MILLION) 53 FIGURE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2022 & 2032(USD MILLION) 53 FIGURE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY EQUIPMENT, 2022 (%) 54 FIGURE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, PROCEDURE SEGMENT ATTRACTIVENESS, 2019–2032 (USD MILLION) 59 FIGURE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2022 & 2032(USD MILLION) 60 FIGURE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY PROCEDURE, 2022 (%) 61 FIGURE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, END USER SEGMENT ATTRACTIVENESS, 2019–2032 (USD MILLION) 65 FIGURE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2022 & 2032(USD MILLION) 66 FIGURE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY END USER, 2022 (%) 67 FIGURE 16 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2022 & 2032 (USD MILLION) 69 FIGURE 17 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY REGION, 2022 70 FIGURE 18 NORTH AMERICA MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION) 71 FIGURE 19 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 72 FIGURE 20 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022 73 FIGURE 21 EUROPE MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION) 78 FIGURE 22 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 79 FIGURE 23 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022 80 FIGURE 24 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION) 91 FIGURE 25 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 92 FIGURE 26 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 & 2032 (USD MILLION) 92 FIGURE 27 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION) 104 FIGURE 28 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 105 FIGURE 29 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2021 & 2030 (USD MILLION) 105 FIGURE 30 GLOBAL MICROSURGERY & SUPER-MICROSURGERY PLAYERS: COMPETITIVE ANALSIS, 2022 111 FIGURE 31 COMPETITOR DASHBOARD: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET 112 FIGURE 32 COMPETITORS PRODUCT ANALYSIS: OPERATING MICROSCOPES 116 FIGURE 33 COMPETITORS PRODUCT ANALYSIS: MICRO FORCEPS 117 FIGURE 34 COMPETITORS PRODUCT ANALYSIS: SUPER MICRO SUTURES 118 FIGURE 35 COMPETITORS PRODUCT ANALYSIS: MICROSURGERY NEEDLE HOLDER 119 FIGURE 36 COMPETITORS PRODUCT ANALYSIS: SURGICAL SCALPEL/ OPHTHALMIC KNIVES 120 FIGURE 37 KONTRON AG: FINANCIAL OVERVIEW SNAPSHOT 122 FIGURE 38 CARL ZEISS MEDITEC AG: FINANCIAL OVERVIEW SNAPSHOT 126 FIGURE 39 CARL ZEISS MEDITEC AG: SWOT ANALYSIS 130 FIGURE 40 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT 136 FIGURE 41 MEDTRONIC: SWOT ANALYSIS 138 FIGURE 42 OLYMPUS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 140 FIGURE 43 SMITH+NEPHEW: FINANCIAL OVERVIEW SNAPSHOT 143 FIGURE 44 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT 146 FIGURE 45 ZIMMER BIOMET: SWOT ANALYSIS 149 FIGURE 46 TOPCON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 151 FIGURE 47 STILLE AB: FINANCIAL OVERVIEW SNAPSHOT 155 FIGURE 48 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT 158 FIGURE 49 B. BRAUN SE: SWOT ANALYSIS 160 FIGURE 50 STRYKER: FINANCIAL OVERVIEW SNAPSHOT 162 FIGURE 51 JOHNSON & JOHNSON SERVICES INC.: FINANCIAL OVERVIEW SNAPSHOT 167 FIGURE 52 JOHNSON & JOHNSON SERVICES INC: SWOT ANALYSIS 168 FIGURE 53 ALCON INC: FINANCIAL OVERVIEW SNAPSHOT 178

提及公司

Kontron AGCarl Zeiss MeditecGlobal Surgical CorporationKarl Kaps GmbH & Co. KGMedtronicOlympus CorporationSmith+NephewZimmer BiometTopcon CorporationStille ABB. Braun SEStrykerBVIJohnson & Johnson Services IncHaag-Streit GroupKLS Martin GroupMicrosurgery Instruments IncPeter Lazic GmbHAlco IncSynovis Micro Companies Alliance Inc.

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們